81 FR 38192 - National Cancer Institute; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 81, Issue 113 (June 13, 2016)

Page Range		38192-38193
FR Document		2016-13930

Federal Register, Volume 81 Issue 113 (Monday, June 13, 2016)

[Federal Register Volume 81, Number 113 (Monday, June 13, 2016)]
[Notices]
[Pages 38192-38193]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-13930]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The contract proposals and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Cancer Diagnostics, Prognostics and Detection.
    Date: June 15, 2016.
    Time: 1:30 p.m. to 5:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 4W032/034, Rockville, MD 20850, (Telephone 
Conference Call).
    Contact Person: Gerard Lacourciere, Ph.D., Scientific Review 
Officer, Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, 9609 Medical 
Center Drive, Room 7W248, Rockville, MD 20892-9750, 240-276-5457, 
gerard.lacourciere@mail.nih.gov.


[[Page 38193]]


    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Software for Measuring Environmental Effects on Cancer.
    Date: June 30, 2016.
    Time: 1:30 p.m. to 5:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 4W030 Rockville, MD 20850, (Telephone Conference 
Call).
    Contact Person: Gerard Lacourciere, Ph.D., Scientific Review 
Officer, Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, 9609 Medical 
Center Drive, Room 7W248, Rockville, MD 20892-9750, 240-276-5457, 
gerard.lacourciere@mail.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: June 8, 2016.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-13930 Filed 6-10-16; 8:45 am]
 BILLING CODE 4140-01-P

Federal Register / Vol. 81, No. 113 / Monday, June 13, 2016 / Notices 38193

This notice is being published less than 15 Research (SBIR) and Small Business or traditional modes of research funding
days prior to the meeting due to the timing Technology Transfer (STTR) funding. (e.g. small business grants).
limitations imposed by the review and Each Challenge winner will receive What does it take to participate in the
funding cycle. Challenge? The team or an individual
$10,000. The Challenge total purse is up
Name of Committee: National Cancer to $100,000. must have a research idea that could
Institute Special Emphasis Panel, Software further the understanding of SUD and is
for Measuring Environmental Effects on DATES: The Challenge begins June 13,
2016. intended to be the basis of the
Cancer.
Date: June 30, 2016. Submission Period: June 13, 2016 to development of a new and potentially
Time: 1:30 p.m. to 5:00 p.m. September 16, 2016, 11:59 p.m., ET. successful startup. The research ‘‘idea’’
Agenda: To review and evaluate contract Judging Period: September 19, 2016 to is the product that your future startup
proposals. October 21, 2016. will offer. Here, the term startup
Place: National Cancer Institute Shady Winners Announced: October 24, ‘‘product’’ is used in its broadest
Grove, 9609 Medical Center Drive, Room 2016. definition. Product is any source of
4W030 Rockville, MD 20850, (Telephone value for the people who become
Conference Call). FOR FURTHER INFORMATION CONTACT: Irina
Sazonova, Ph.D., M.Sc., Health Scientist customers. Services, subscriptions,
Contact Person: Gerard Lacourciere, Ph.D.,
Scientific Review Officer, Research Administrator, Office of Translational software as a service (SaaS), physical/
Technology and Contract Review Branch, Initiatives and Program Innovations tangible products, aggregations, etc.
Division of Extramural Activities, National could all provide value and thus be
(OTIPI), NIDA Challenge Administrator,
Cancer Institute, 9609 Medical Center Drive, considered startup products. The
National Institute on Drug Abuse
Room 7W248, Rockville, MD 20892–9750, startup product could be the result of
(NIDA), 6001 Executive Blvd. Room
240–276–5457, gerard.lacourciere@ novel scientific discoveries, repurposing
mail.nih.gov. 4206, MSC 9555 Bethesda, MD 20892–
an existing technology for a new use,
9555. Phone: (301) 827–9564, Email:
(Catalogue of Federal Domestic Assistance extending a research observation into a
Program Nos. 93.392, Cancer Construction; irina.sazonova@nih.gov.
different area, devising a new business
93.393, Cancer Cause and Prevention SUPPLEMENTARY INFORMATION: The model or distribution/delivery channel
Research; 93.394, Cancer Detection and Institute’s Statutory Authority to that unlocks value currently concealed,
Diagnosis Research; 93.395, Cancer Conduct the Challenge. NIDA is
Treatment Research; 93.396, Cancer Biology
or simply bringing a product or service
conducting this Challenge under the to previously underserved set of
Research; 93.397, Cancer Centers Support; America Creating Opportunities to
93.398, Cancer Research Manpower; 93.399, customers. The Founder (the teams or
Cancer Control, National Institutes of Health,
Meaningfully Promote Excellence in an individual) must demonstrate
HHS) Technology, Education, and Science through the Submission the passion,
(COMPETES) Reauthorization Act of drive, discipline, ability to work
Dated: June 8, 2016. 2010, 15 U.S.C. 3719. The general
Melanie J. Gray,
collaboratively and willingness to push
purpose of NIDA is to conduct and forward under conditions of extreme
Program Analyst, Office of Federal Advisory support biomedical and behavioral business uncertainty.
Committee Policy. research, health-services research, The winners of this Challenge are
[FR Doc. 2016–13930 Filed 6–10–16; 8:45 am] research training, and health- encouraged to use the prize funds to
BILLING CODE 4140–01–P information dissemination with respect develop a minimum viable proof (MVP)
to the prevention of drug abuse and the as quickly as possible and to obtain
treatment of drug abusers. This customer feedback to discover if MVP
DEPARTMENT OF HEALTH AND Challenge is consistent with and meets the customer needs. If the product
HUMAN SERVICES advances the mission of NIDA as prototype is successfully validated,
described in 42 U.S.C. 285o in that it winners are encouraged to create or
National Institutes of Health
supports new and potential biotech further advance their biotech startup no
Announcement of Requirements and start-ups in the development of research later than 6 months after the prize is
Registration for ‘‘$100,000 for Start a ideas that would further an awarded. Post Challenge, as with all
SUD Startup’’ Challenge understanding of neurobiology as it other NIH grant applicants, NIDA staff
relates to SUD. will provide dedicated assistance and
SUMMARY: The National Institute on Subject of Challenge. NIDA is excited guidance about the NIH grant
Drug Abuse (NIDA), one of the to announce the first competition for submission process, including
components of the National Institutes of biomedical scientists with the goal to submissions for the SBIR/STTR grants.
Health (NIH), announces the ‘‘$100,000 support research ideas that would The research idea must be broad
for Start a SUD Startup’’ Challenge. The further an understanding of enough to address multiple conditions,
Challenge goal is to support research neurobiology as it relates to SUD and diseases, or indications consistent with
ideas that would further an that are intended to be the basis for the SUD or be specific for prevention and
understanding of neurobiology as it development of a new and potentially treatments of SUD. For example, if your
relates to Substance Use Disorders successful start-up. NIDA hopes that idea can only work for cancer or
(SUD) and that are intended to be the participation in the contest will enable diabetes, entering this Challenge is not
basis for the development of a new and scientists to test whether their research appropriate. However, if the plan is to
potentially successful start-up. NIDA ideas can be fostered into a biotech test an idea for a research tool that
hopes that participation in the contest startup. In 2016, NIDA will award up to would further an understanding of
will enable scientists to test the $100,000 in prizes to up to 10 winners neurobiology or epigenetics relevant to
srobinson on DSK5SPTVN1PROD with NOTICES

hypothesis that their research idea can of the contest, $10,000 each. SUD to progress faster and with greater
be fostered into a biotech startup, and Are you a biomedical scientist who fidelity, entering this Challenge is
that eventually any newly created believes that he/she has a research idea appropriate.
startups will contribute to the pool of for a biotech start-up? This Challenge is Rules for Participating in the
innovative small business companies unique because NIDA intends to fund Challenge. The Challenge is open to any
that can successfully compete for the ‘‘would be’’ startup Founders much Founder 18 years of age or older. No
NIDA’s Small Business Innovation earlier than most investors, incubators, prior startup experience is necessary. A

VerDate Sep<11>2014 20:48 Jun 10, 2016 Jkt 238001 PO 00000 Frm 00067 Fmt 4703 Sfmt 4703 E:\FR\FM\13JNN1.SGM 13JNN1

Document Created: 2018-02-08 07:39:35
Document Modified: 2018-02-08 07:39:35

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		June 15, 2016.
FR Citation		81 FR 38192

81 FR 38192 - National Cancer Institute; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 81, Issue 113 (June 13, 2016)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health